Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Kieseier BC, Sahraian MA, Coles AJ, Hartung HP, Havrdova E, Selmaj K, Margolin DH, Palmer J, Oyuela P
Mult Scler Relat Disord. 2014 Nov; 3(6):756. Epub 2014 Nov 21. PMID: 25891599.Abstract